Operator experience and sample quality in genetic amniocentesis

Robert A. Welch, Soha Salem-Elgharib, Anne E. Wiktor, Daniel L. Van Dyke, William B. Blessed

Research output: Contribution to journalArticle

25 Citations (Scopus)

Abstract

Objective: We sought to relate the frequency of maternal cell contamination in amniotic fluid samples that were submitted to a single laboratory for cytogenetic analysis to the experience and training of the physician who performed the amniocentesis. Study design: We reviewed the database of a single cytogenetics laboratory to compare the number of amniocenteses that were performed annually per physician to the rate of maternal cell contamination in genetic amniocentesis samples. Only samples that resulted in a 46 XY male karyotype were studied so that maternal cell contamination could be identified as having occurred when the karyotype revealed ≥1 cell with 2 X chromosomes. Samples were categorized as being submitted by a physician who submitted ≥50 or more samples annually versus <50 samples to this laboratory. The frequency of maternal cell contamination was compared with annual operator volume with 2 × 2 tables and analyzed by chi-squared testing. Results: Between 2000 and 2004, the laboratory received 6332 mid-trimester amniotic fluid samples that generated a male karyotype result. Fourteen of 2081 samples (0.67%) that were submitted by physicians who submitted <50 samples grew ≥1 46 XX cells, compared with 8 of 4251 samples (0.19%; chi-squared, 9.47; degrees of freedom, 1; P = .0021). Conclusion: Maternal cell contamination occurs more frequently in genetic amniocentesis samples that are obtained by physicians who perform <50 genetic amniocenteses annually.

Original languageEnglish (US)
Pages (from-to)189-191
Number of pages3
JournalAmerican Journal of Obstetrics and Gynecology
Volume194
Issue number1
DOIs
StatePublished - Jan 2006

Fingerprint

Amniocentesis
Mothers
Physicians
Karyotype
Amniotic Fluid
Cytogenetic Analysis
X Chromosome
Cytogenetics
Databases

Keywords

  • Genetic amniocentesis
  • Maternal cell contamination

ASJC Scopus subject areas

  • Medicine(all)
  • Obstetrics and Gynecology

Cite this

Welch, R. A., Salem-Elgharib, S., Wiktor, A. E., Van Dyke, D. L., & Blessed, W. B. (2006). Operator experience and sample quality in genetic amniocentesis. American Journal of Obstetrics and Gynecology, 194(1), 189-191. https://doi.org/10.1016/j.ajog.2005.05.033

Operator experience and sample quality in genetic amniocentesis. / Welch, Robert A.; Salem-Elgharib, Soha; Wiktor, Anne E.; Van Dyke, Daniel L.; Blessed, William B.

In: American Journal of Obstetrics and Gynecology, Vol. 194, No. 1, 01.2006, p. 189-191.

Research output: Contribution to journalArticle

Welch, RA, Salem-Elgharib, S, Wiktor, AE, Van Dyke, DL & Blessed, WB 2006, 'Operator experience and sample quality in genetic amniocentesis', American Journal of Obstetrics and Gynecology, vol. 194, no. 1, pp. 189-191. https://doi.org/10.1016/j.ajog.2005.05.033
Welch, Robert A. ; Salem-Elgharib, Soha ; Wiktor, Anne E. ; Van Dyke, Daniel L. ; Blessed, William B. / Operator experience and sample quality in genetic amniocentesis. In: American Journal of Obstetrics and Gynecology. 2006 ; Vol. 194, No. 1. pp. 189-191.
@article{01ee1d5abc434fd3b5e9318f6f98ba64,
title = "Operator experience and sample quality in genetic amniocentesis",
abstract = "Objective: We sought to relate the frequency of maternal cell contamination in amniotic fluid samples that were submitted to a single laboratory for cytogenetic analysis to the experience and training of the physician who performed the amniocentesis. Study design: We reviewed the database of a single cytogenetics laboratory to compare the number of amniocenteses that were performed annually per physician to the rate of maternal cell contamination in genetic amniocentesis samples. Only samples that resulted in a 46 XY male karyotype were studied so that maternal cell contamination could be identified as having occurred when the karyotype revealed ≥1 cell with 2 X chromosomes. Samples were categorized as being submitted by a physician who submitted ≥50 or more samples annually versus <50 samples to this laboratory. The frequency of maternal cell contamination was compared with annual operator volume with 2 × 2 tables and analyzed by chi-squared testing. Results: Between 2000 and 2004, the laboratory received 6332 mid-trimester amniotic fluid samples that generated a male karyotype result. Fourteen of 2081 samples (0.67{\%}) that were submitted by physicians who submitted <50 samples grew ≥1 46 XX cells, compared with 8 of 4251 samples (0.19{\%}; chi-squared, 9.47; degrees of freedom, 1; P = .0021). Conclusion: Maternal cell contamination occurs more frequently in genetic amniocentesis samples that are obtained by physicians who perform <50 genetic amniocenteses annually.",
keywords = "Genetic amniocentesis, Maternal cell contamination",
author = "Welch, {Robert A.} and Soha Salem-Elgharib and Wiktor, {Anne E.} and {Van Dyke}, {Daniel L.} and Blessed, {William B.}",
year = "2006",
month = "1",
doi = "10.1016/j.ajog.2005.05.033",
language = "English (US)",
volume = "194",
pages = "189--191",
journal = "American Journal of Obstetrics and Gynecology",
issn = "0002-9378",
publisher = "Mosby Inc.",
number = "1",

}

TY - JOUR

T1 - Operator experience and sample quality in genetic amniocentesis

AU - Welch, Robert A.

AU - Salem-Elgharib, Soha

AU - Wiktor, Anne E.

AU - Van Dyke, Daniel L.

AU - Blessed, William B.

PY - 2006/1

Y1 - 2006/1

N2 - Objective: We sought to relate the frequency of maternal cell contamination in amniotic fluid samples that were submitted to a single laboratory for cytogenetic analysis to the experience and training of the physician who performed the amniocentesis. Study design: We reviewed the database of a single cytogenetics laboratory to compare the number of amniocenteses that were performed annually per physician to the rate of maternal cell contamination in genetic amniocentesis samples. Only samples that resulted in a 46 XY male karyotype were studied so that maternal cell contamination could be identified as having occurred when the karyotype revealed ≥1 cell with 2 X chromosomes. Samples were categorized as being submitted by a physician who submitted ≥50 or more samples annually versus <50 samples to this laboratory. The frequency of maternal cell contamination was compared with annual operator volume with 2 × 2 tables and analyzed by chi-squared testing. Results: Between 2000 and 2004, the laboratory received 6332 mid-trimester amniotic fluid samples that generated a male karyotype result. Fourteen of 2081 samples (0.67%) that were submitted by physicians who submitted <50 samples grew ≥1 46 XX cells, compared with 8 of 4251 samples (0.19%; chi-squared, 9.47; degrees of freedom, 1; P = .0021). Conclusion: Maternal cell contamination occurs more frequently in genetic amniocentesis samples that are obtained by physicians who perform <50 genetic amniocenteses annually.

AB - Objective: We sought to relate the frequency of maternal cell contamination in amniotic fluid samples that were submitted to a single laboratory for cytogenetic analysis to the experience and training of the physician who performed the amniocentesis. Study design: We reviewed the database of a single cytogenetics laboratory to compare the number of amniocenteses that were performed annually per physician to the rate of maternal cell contamination in genetic amniocentesis samples. Only samples that resulted in a 46 XY male karyotype were studied so that maternal cell contamination could be identified as having occurred when the karyotype revealed ≥1 cell with 2 X chromosomes. Samples were categorized as being submitted by a physician who submitted ≥50 or more samples annually versus <50 samples to this laboratory. The frequency of maternal cell contamination was compared with annual operator volume with 2 × 2 tables and analyzed by chi-squared testing. Results: Between 2000 and 2004, the laboratory received 6332 mid-trimester amniotic fluid samples that generated a male karyotype result. Fourteen of 2081 samples (0.67%) that were submitted by physicians who submitted <50 samples grew ≥1 46 XX cells, compared with 8 of 4251 samples (0.19%; chi-squared, 9.47; degrees of freedom, 1; P = .0021). Conclusion: Maternal cell contamination occurs more frequently in genetic amniocentesis samples that are obtained by physicians who perform <50 genetic amniocenteses annually.

KW - Genetic amniocentesis

KW - Maternal cell contamination

UR - http://www.scopus.com/inward/record.url?scp=29544432490&partnerID=8YFLogxK

UR - http://www.scopus.com/inward/citedby.url?scp=29544432490&partnerID=8YFLogxK

U2 - 10.1016/j.ajog.2005.05.033

DO - 10.1016/j.ajog.2005.05.033

M3 - Article

C2 - 16389030

AN - SCOPUS:29544432490

VL - 194

SP - 189

EP - 191

JO - American Journal of Obstetrics and Gynecology

JF - American Journal of Obstetrics and Gynecology

SN - 0002-9378

IS - 1

ER -